AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-23687686_ITM" title="Facts and information about Covalent Group Inc announces $3.4 M in new business awards to conduct clinical research studies in North America and Europe.">Covalent Group Inc announces $3.4 M in new business awards to conduct clinical research studies in North America and Europe.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
Covalent Group Inc announces $3.4 M in new business awards to conduct clinical research studies in North America and Europe.
(From Chemical Business NewsBase - Press Release)
Covalent Group Inc announced the awarding of contracts with five different pharmaceutical companies whose corporate headquarters are located in the US and Western Europe. The total estimated value of the new business awards is $3.4 M. Services will be provided in about 20 countries in North America as well as Western, Central and Eastern Europe. Among these services will be clinical trial design consulting, project …
Related articles from newspapers, magazines, journals, and more
-
- Covalent Group Inc announces $3.2 M of new clinical trial contracts.
-
News wire article from: Asia Africa Intelligence Wire
February 3, 2003
700+ words
-
- Covalent announces $3.7 M in new business awards.
-
News wire article from: Asia Africa Intelligence Wire
March 31, 2003
700+ words
-
- Covalent announces $2.3 M in new business awards.
-
News wire article from: Asia Africa Intelligence Wire
November 17, 2003
700+ words
